We’ve had a very successful year, with 8756 new applications and 25 new hires during 2022, including our ventures! Thank you to all the applicants for such huge interest.

To check out our open positions, click on the button below.

We are very proud to have co-hosted the Longevity Investors Lunch with Longevity Investors Conference and Biolytica this year!

The event, that took place during WEF in Davos, was a success where key longevity experts met with high level investors and exchanged their view on longevity as well as shared key insights regarding investing in longevity and new research areas.

You can read more about the event on Moneycab and Longevity.Technology, while enjoying a few photos from the event.

Welcome our new additions to the Maximon family:

Gergana Nikolova, Event Manager at Longevity Investors Conference

Gergana brings 18 years of experience in strategic communications and planning, Public Relations and Event management.

Andjela Martinovic, Junior Science Analyst & Venture Builder

Andjela worked in the fields of probiotics and nutrition, which also developed into her PhD area of expertise. She also has experience as a Venture Analyst, which sparked her interest in VC companies.

Andrea Rutz Rodriguez, Junior Venture Builder

Andrea holds a BA in International Affairs, during which she gained valuable experience in the car industry and discovered her interest in the start-up ecosystem.

Our first portfolio company Avea Life launched The Avea Collagen Activator - a revolutionary product that promotes rejuvenation from your cells to your skin, with a wide range of health benefits above and beyond collagen production.

Developed in collaboration with scientists from ETH Zurich, it features a patent-pending blend of amino acids - Colgevity™ - that has been shown to ideally activate collagen production.